NSPR Message Board Post 9274964 | InspireMD Inc.
home / stock / nspr / nspr message board
Lbradiology1
(investorshub)
Posted on: Nov/29/2022 12:23:33
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170557871
Challenges What I THINK I know:
News, Short Squeeze, Breakout and More Instantly...
-
Series H warrants exercisable following release of positive outcomes results related to one-year follow-up from the Company’s C-GUARDIANS pivotal trial. Participating warrant holders include Marshall Wace, OrbiMed, Rosalind, Nantahala, Soleus, Velan, and certain InspireMD Board m...
-
Data demonstrate lowest reported primary endpoint event rate of 1.95% through twelve months post-procedure for any carotid stent or embolic protection device pivotal trial Study results to support a Premarket Approval (PMA) application to FDA in H2 2024 U.S. commercial launch of...